Transplantation of neural stem cells improved neurologic and motor function for adults with chronic ischemic stroke at 12 ...

Remedy Pharmaceuticals, a leader in stroke drug development today announced efficacy data from the Phase 2 GAMES-RP and Phase 3 CHARM studies of CIRARA (intravenous glyburide) for the treatment of ...

The evolution of functional assessments for spinal muscular atrophy (SMA) highlights the challenges of adapting pediatric ...

The following is a summary of “Association of blood pressure parameters on early neurological deterioration in patients with ...

For patients with acute ischemic stroke (AIS) whose symptoms began 4.5 to 24 hours earlier, alteplase is associated w ...

The National Institutes of Health Stroke Scale (NIHSS) is accepted as the definitive clinical examination to assess stroke severity. This project examined barriers to implementation and NIHSS use ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for troriluzole for the treatment of adults with spinocerebellar ataxia (SCA).

A project was developed to determine the barriers to NIHSS use by the nursing staff ... and a 5-point Likert scale (1 = weak belief, 5 = strong belief) to measure staff nurse beliefs.

International Stroke Conference of the American Heart Association/American Stroke Association was held from Feb. 5 to 7 in ...

Fins is the E. William Davis Jr., M.D., professor of medical ethics, chief of the Division of Medical Ethics, and a professor of medicine at Weill Cornell Medicine and chair of the Hastings Center ...

President Donald Trump and his newly created Department of Government Efficiency, or DOGE, have made quick work in its goals to slash spending and shrink the federal government. DOGE is led by the ...

Top universities and medical centers stand to lose $100 million a year or more if a sweeping change to how the National Institutes of Health reimburses research costs takes effect on Monday.